Tasly Pharmaceutical Group Co Ltd - Company Profile
Powered by 
All the data and insights you need on Tasly Pharmaceutical Group Co Ltd in one report.
$295
- Save hours of research time and resources with
our up-to-date Tasly Pharmaceutical Group Co Ltd Strategy Report
- Understand Tasly Pharmaceutical Group Co Ltd position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
Business Description
Tasly Pharmaceutical Group Co Ltd (Tasly) is involved in the development, manufacture and distribution of chemical medicine, modern chinese medicine, biological medicine, healthcare products and functional food.
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
R&D Overview
The company is focusing on major four therapeutic areas cardiovascular, tumour immunity, digestive metabolism and neuroscience. It is also involved in developing platforms for development, preclinical research, and clinical research, with a focus on treating major diseases, aiming to establish a platform that is either the "first" or the "best." Tasly also collaborates with several overseas scientific research institutes and universities. In FY2022, the company invested CNY740.6 million on its R&D activities.
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer